Literature DB >> 323117

Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.

C G Lamers, J H Van Tongeren.   

Abstract

To evaluate the usefulness of provocation tests in the diagnosis of the Zollinger-Ellison (ZE) syndrome stimulation tests with calcium, 15 mg/kg. 3 h, and secretin GIH, 1 U/kg.30 s, were performed in 15 patients with histologically proven or suspected ZE syndrome. Nine of these 15 patients were without previous gastric surgery and in them meal stimulated serum gastrin levels were measured as well. These tests were also performed in normal subjects and in patients with duodenal ulcer, antrectomy, total gastrectomy, and achlorhydria. All tests were considered to be positive if a more than 50% increase in serum gastrin was found. The results indicate that secretin stimulation is the provocation test of first choice in the diagnosis of this syndrome. This test is most valuable for the following reasons: (1) there were few (two out of 15) false-negative test results in ZE patients; (2) there were no false-positive tests in 69 patients without gastrinoma; (3) it was easy and quick to perform; and (4) there were no adverse reactions. The two ZE patients with negative secretin stimulation tests had negative calcium provocation tests as well, in spite of histologically proven gastrinoma. In 11 patients with suspected or proven ZE syndrome and basal serum gastrin levels of less than 1000 pg/ml a rather good correlation (r = 0-841; P less than 0-01) was found between the percental increase in serum gastrin after stimulation by calcium and secretin. Meal stimulated serum gastrin levels are helpful only in patients without previous gastric surgery.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323117      PMCID: PMC1411301          DOI: 10.1136/gut.18.2.128

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Two types of Zollinger-Ellison syndrome: immunofluorescent, cytochemical and ultrastructural studies of the antral and pancreatic gastrin cells in different clinical states.

Authors:  J M Polak; B Stagg; A G Pearse
Journal:  Gut       Date:  1972-07       Impact factor: 23.059

Review 2.  Radioimmunoassay in gastroenterology.

Authors:  S A Berson; R S Yalow
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

Review 3.  Zollinger-Ellison syndrome.

Authors:  J I Isenberg; J H Walsh; M I Grossman
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

4.  Clinical role of serum gastrin measurements in the Zollinger-Ellison syndrome.

Authors:  J C Thompson; D D Reeder; H H Bunchman
Journal:  Am J Surg       Date:  1972-08       Impact factor: 2.565

5.  Calcium challenge in the Zollinger-Ellison syndrome.

Authors:  E Passaro; N Basso; J H Walsh
Journal:  Surgery       Date:  1972-07       Impact factor: 3.982

6.  Gastric secretion in duodenal ulcer, with particular reference to the diagnosis of Zollinger-Ellison syndrome.

Authors:  M D Kaye; J Rhodes; P Beck
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

7.  Antral-gastrin-cell hyperplasia in peptic-ulcer disease.

Authors:  P C Ganguli; J M Polak; A G Pearse; J B Elder; M Hegarty
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

8.  Production and evaluation of antibodies for the radioimmunoassay of gastrin.

Authors:  J F Rehfeld; F Stadil; B Rubin
Journal:  Scand J Clin Lab Invest       Date:  1972-10       Impact factor: 1.713

9.  Hypergastrinaemia in chronic renal failure.

Authors:  M G Korman; M C Laver; J Hansky
Journal:  Br Med J       Date:  1972-01-22

10.  Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).

Authors:  W Creutzfeldt; R Arnold; C Creutzfeldt; N S Track
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

View more
  19 in total

1.  Secretin provocation in normal and duodenal ulcer subjects. Is the gastrin rise in Zollinger-Ellison syndrome paradoxic or exaggeration?

Authors:  C E Brady; S J Utts; J Dev
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

Review 2.  Pathophysiology of gastrointestinal hormones. Implications for paediatrics.

Authors:  I Henrichs; W M Teller
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

3.  Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism.

Authors:  J R Farndon; J M Geraghty; W G Dilley; S Handwerger; G S Leight
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Clinical features and diagnosis of alimentary endocrine tumours.

Authors:  R B Welbourn
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

5.  Serum gastrin levels in response to exogenous secretin in patients with duodenal ulcer--false positive response occurring in case of endoscopically active ulcer.

Authors:  K Shiratori; S Watanabe; T Takeuchi
Journal:  Gastroenterol Jpn       Date:  1982-04

6.  Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.

Authors:  Scott H Long; Marc J Berna; Michelle Thill; Andrea Pace; Tapas K Pradhan; K Martin Hoffmann; Jose Serrano; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2007-08-21       Impact factor: 5.958

7.  Clinical significance of glucagon provocation test in the diagnosis of hypergastrinemia.

Authors:  C Nakanome; A Ishimori; Y Goto; T Yamazaki; J Kameyama; I Sasaki; M Inui; Y Furukawa; K Komatsu
Journal:  Gastroenterol Jpn       Date:  1981

8.  Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; J L Doppman; M J Collen; J W Harmon; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

9.  Serum gastrin responses to bombesin and food in patients with hypergastrinemia.

Authors:  J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

10.  Removal of gastrinomas for control of Zollinger-Ellison syndrome.

Authors:  J W Harmon; J A Norton; M J Collin; A G Krudy; T H Shawker; J L Doppman; J d'Avis; R T Jensen
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.